Physician

Elena Geraymovych, M.D.

According to 2025 Medicare claims, Elena Geraymovych, M.D. (NPI: 1073775342) practices ophthalmology in the Reno, NV market, with the plurality of this provider's patient population coming from Washoe, NV. This provider's primary affiliated billing organization is NEVADA RETINA ASSOCIATES, STEVEN M. FRIEDLANDER, M.D., LTD. (NPI: 1548220189; TIN: 88-0383202) and primary practice location at 89703-4633.

Geraymovych's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,139 traditional Medicare patients, billed 74,934 HCPCS/CPT codes, and received $4,310,593 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 421 prescription claims across 185 beneficiaries totaling $21,305 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 13 records totaling $6,830. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $200,501 to $4,310,593. Similarly, Part D prescription costs have risen steadily, from $4,216 to $21,305. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.2M$4.3M2015 Medicare payment: $200,501 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $222,015 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,956,631 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,328,898 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,028,236 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,866,086 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,123,191 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,698,622 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,170,957 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,310,593 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152231,490$200,501
20163121,844$222,015
20171,0779,634$1,956,631
20181,17411,229$2,328,898
20191,30813,294$3,028,236
20201,03611,383$2,866,086
20211,08312,061$3,123,191
20221,12017,336$3,698,622
20231,12753,111$4,170,957
20241,13974,934$4,310,593

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$11K$21K2015 Drug cost: $4,216 (USD; Tot_Drug_Cst)2016 Drug cost: $4,662 (USD; Tot_Drug_Cst)2017 Drug cost: $11,249 (USD; Tot_Drug_Cst)2018 Drug cost: $15,952 (USD; Tot_Drug_Cst)2019 Drug cost: $20,664 (USD; Tot_Drug_Cst)2020 Drug cost: $13,583 (USD; Tot_Drug_Cst)2021 Drug cost: $14,091 (USD; Tot_Drug_Cst)2022 Drug cost: $15,856 (USD; Tot_Drug_Cst)2023 Drug cost: $16,743 (USD; Tot_Drug_Cst)2024 Drug cost: $21,305 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153158$4,216
20162365$4,662
201787205$11,249
2018109273$15,952
2019130316$20,664
2020130352$13,583
2021128311$14,091
2022147399$15,856
2023166411$16,743
2024185421$21,305

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg3082,570$656
67028Injection of drug into eye6302,300$95
92014Established patient complete exam of visual system290293$91
92134Imaging of retina9222,647$30
92250Photography of the retina331479$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1315,831$6,495
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol14710$2,141
Brimonidine TartrateBrimonidine Tartrate301,425$874
TobramycinTobramycin811,849$422
Dorzolamide HclDorzolamide Hcl211,096$367

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.13$6,830Carl Zeiss Meditec Cataract Technology Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Elena Geraymovych, M.D.?

Tedicare shows public-source Medicare data for Elena Geraymovych, M.D. (NPI 1073775342), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Elena Geraymovych, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Elena Geraymovych, M.D.?

Elena Geraymovych, M.D. is linked to NEVADA RETINA ASSOCIATES, STEVEN M. FRIEDLANDER, M.D., LTD. (billing NPI 1548220189) in the available physician profile data.

Does Elena Geraymovych, M.D. have Open Payments data?

Elena Geraymovych, M.D. has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.